Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
400 participants
OBSERVATIONAL
2024-01-09
2027-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
SEEG Investigation of Mood Dysregulation in Epilepsy
NCT03097809
Seizure Detection and Warning System in Epilepsy Patients
NCT02555410
Assessment of Severity and Prognosis for Patients With Status Epileptics(SE)
NCT02269137
Detecting Generalized Tonic-Clonic Seizures With a Seizure Detection and Warning System in Epilepsy Patients
NCT02371200
Localizing the Epileptogenic Zone With High Resolution Electroencephalography
NCT01090934
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Stereoelectroencephalography (SEEG)
Participants undergoing SEEG as part of standard of care.
Stereoelectroencephalography (SEEG)
Participants will under Stereoelectroencephalography (SEEG) as part of standard of care. This is not assigned by the protocol.
Control Group
Participants not undergoing SEEG as part of standard of care.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Stereoelectroencephalography (SEEG)
Participants will under Stereoelectroencephalography (SEEG) as part of standard of care. This is not assigned by the protocol.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* availability of complete non-invasive presurgical work-up (including high-resolution MRI according to the in-center epilepsy protocol, video-telemetry with the recording of a minimum of one habitual clinic and EEG seizure, available as original files for review)
Exclusion Criteria
* no protocol MRI in center
* subdural/GRID electrodes
15 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Duke University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Birgit Frauscher, MD PD
Role: PRINCIPAL_INVESTIGATOR
Duke University
Alexandra Astner-Rohracher
Role: PRINCIPAL_INVESTIGATOR
Christian Doppler University Hospital Paracelsus Medical University Salzburg and Centre for Cognitive Neuroscience Salzburg
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Florida College of Medicine
Gainesville, Florida, United States
Northwestern University
Chicago, Illinois, United States
Duke University Health System
Durham, North Carolina, United States
Presbyterian-Shadyside Hospital
Pittsburgh, Pennsylvania, United States
Monash University
Melbourne, Victoria, Australia
Mater Health
Brisbane, , Australia
Alfred Health
Melbourne, , Australia
Christian Doppler University Hospital Paracelsus Medical University Salzburg and Centre for Cognitive Neuroscience Salzburg
Salzburg, , Austria
Dalhousie Universiry and Hospital
Dalhousie, Nova Scotia, Canada
Wester University
London, Ontario, Canada
Departmet of Neurology, Masaryk University Brno
Brno, , Czechia
Danish Epilepsy Centre, Aarhus Universitets Hospital
Aarhus, , Denmark
Grenoble Institute of Neurosciences, Centre Hospitalier Universitaire Grenoble Alpes
Grenoble, , France
Epilepsy Department University Hospitals of Marseille
Marseille, , France
Epilepsy Centre, University Hospital Freiburg
Freiburg im Breisgau, , Germany
University School of Medicine Kyoto
Kyoto, , Japan
"Carol Davila" University of Medicine and Pharmacy
Bucharest, , Romania
Hospital Universitario y Politecnico La Fe
Valencia, , Spain
Department of Clinical Neurosciences chez CHUV; Centre Hospitalier Universitaire Vaudois
Lausanne, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Astner-Rohracher A, Ho A, Archer J, Bartolomei F, Brazdil M, Cacic Hribljan M, Castellano J, Dolezalova I, Fabricius ME, Garces-Sanchez M, Hammam K, Ikeda A, Ikeda K, Kahane P, Kalamangalam G, Kalss G, Khweileh M, Kobayashi K, Kwan P, Laing JA, Leitinger M, Lhatoo S, Makhalova J, McGonigal A, Mindruta I, Mizera MM, Neal A, Oane I, Parikh P, Perucca P, Pizzo F, Rocamora R, Ryvlin P, San Antonio Arce V, Schuele S, Schulze-Bonhage A, Suller Marti A, Urban A, Villanueva V, Vilella Bertran L, Whatley B, Beniczky S, Trinka E, Zimmermann G, Frauscher B. Prognostic value of the 5-SENSE Score to predict focality of the seizure-onset zone as assessed by stereoelectroencephalography: a prospective international multicentre validation study. BMJ Neurol Open. 2024 Aug 21;6(2):e000765. doi: 10.1136/bmjno-2024-000765. eCollection 2024.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00113692
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.